Jaguar Health Files 8-K/A Amendment
Ticker: JAGX · Form: 8-K/A · Filed: Apr 25, 2025 · CIK: 1585608
| Field | Detail |
|---|---|
| Company | Jaguar Health, INC. (JAGX) |
| Form Type | 8-K/A |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-obligation, equity-sale
Related Tickers: JAGX
TL;DR
Jaguar Health amended its 8-K filing regarding material agreements and equity sales.
AI Summary
Jaguar Health, Inc. filed an 8-K/A on January 29, 2025, to amend a previous filing. The amendment pertains to the entry into a material definitive agreement, the creation of a direct financial obligation, and unregistered sales of equity securities. Specific details regarding the agreement, financial obligation, and equity sales are not fully elaborated in the provided text but are the subject of this amendment.
Why It Matters
This filing indicates Jaguar Health is amending previous disclosures related to significant financial agreements and equity transactions, which could impact its financial obligations and shareholder structure.
Risk Assessment
Risk Level: medium — Amendments to material definitive agreements and financial obligations can signal changes in a company's financial health or strategic direction.
Key Players & Entities
- Jaguar Health, Inc. (company) — Registrant
- January 29, 2025 (date) — Date of earliest event reported
- 200 Pine Street Suite 400 (address) — Principal Executive Offices
- San Francisco, California (location) — Principal Executive Offices
- 94104 (zip_code) — Principal Executive Offices
FAQ
What specific material definitive agreement is Jaguar Health amending?
The provided text does not specify the details of the material definitive agreement being amended, only that an amendment is being filed.
What is the nature of the direct financial obligation or off-balance sheet arrangement being amended?
The filing indicates an amendment related to the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specific details are not provided in this excerpt.
What unregistered sales of equity securities are being amended?
The filing notes an amendment concerning unregistered sales of equity securities, but the specifics of these sales are not detailed in the provided text.
What is the purpose of filing an 8-K/A instead of an initial 8-K?
An 8-K/A is filed to amend a previously filed Current Report on Form 8-K, indicating that information previously reported needs to be corrected or supplemented.
When was the original event that this 8-K/A is amending?
The filing states the date of the earliest event reported is January 29, 2025, which is the date this 8-K/A is filed, implying the original event or reporting was around this date.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 25, 2025 regarding Jaguar Health, Inc. (JAGX).